Efficacy/Effectiveness and safety of emicizumab prophylaxis of people with hemophilia A: a systematic review and meta-analysis

CONCLUSIONS: Emicizumab prophylaxis was superior in reducing the ABR-all when compared with prophylaxis with FVIII or BPA.PMID:38066708 | DOI:10.1080/17474086.2023.2293096

Source: Expert Review of Hematology - December 9, 2023 Category: Hematology Authors: Roberto L úcio Muniz Ricardo Mesquita Camelo Maiara Silva Ara újo Mariana Michel Barbosa Augusto Afonso Guerra Francisco de Assis Acurcio Juliana Alvares-Teodoro Source Type: research